There is a gap in knowledge regarding what pharmaceutical therapies should be used with patients who have myocardial injury but who have not had a type 1 myocardial infarction. In this video, AJM Editor-in-Chief Joseph S. Alpert, MD discusses new research into the use of high-intensity statins with these patients. You can read “Statin Therapy and Intensity: Prognosis in Patients with Myocardial Injury” by Kadesjo et al in the December 2021 issue of the American Journal of Medicine at amjmed.com.
